Guests Matthew Miskin, Steve Center, and Robert Davis discuss market dependency on a dovish Fed, EV production outlook, and Merck's new lung disease drug. Topics include managing market expectations, Powell's financial policy approach, electric vehicle transition challenges, competition in the auto industry, innovative drug approval for pulmonary arterial hypertension, and drug pricing in healthcare.